Latest Breast Cancer Update 2019-2020: All Facts And Figures

Approximately 1 million breast cancer cases are found in India alone, making it one of the most common cancers. To help fight the disease, breast cancer treatment in India and the rest of the world go under a review every year. These breast cancer updates 2020 help Breast cancer specialist doctors to give better treatments to patients.

Breast cancer overview for 2019-2020

Between the years 2019 and 2020, several research studies have been done on preventing and treating breast cancer. For the year 2019, approximately 268,000 invasive breast cancer cases in women were predicted. Similarly, the number of deaths from the cancer type is estimated to be 41,760 women and 500 men—the average estimate of breast cancer survival changes over the years. For instance, the survival rate is 91% at five years after diagnosis, 84% after ten years, and 80% after 15 years. However, this rate is subjected to change depending on when it is diagnosed and the subtype of cancer. Within the year 2019-2020, new ways of breast cancer treatment in India and outside have cropped up. Moreover, the ongoing pandemic has had a significant role in the research on treatment methods.

2020 updates for breast cancer

One significant breast cancer update 2020 is a delay in cancer screening and surgery due to the ongoing pandemic. Before COVID-19 hit us, new research provided more evidence of chemotherapy’s positive effects before the surgery. It paves the way to better treatment from the Best Breast Cancer Doctor in Delhi. Yet another update in 2020 is a study that proved the possibility of breast cancers that are estrogen receptor-negative and progesterone receptor-positive of being a separate sub-type.

The latest news on breast cancer survival

Between 2019 and 2020, the latest news on breast cancer survival relates to the use of antimetabolite chemotherapy, Xeloda, and its effect on the survival and recurrence rates. According to a recent study, the treatment method led to 85% of patients and 83% survivors with no recurrence for about five years. However, breast cancer survival rates depend on factors like cancer subtype and the stage of its diagnosis. The five-year survival rates for HR+/HER2-, HR+/HER2+, HR-/HER2+, and HR-/HER2 are 92%, 89%, 83%, and 77%. Similarly, it is 99% for localized, 86% for regional, and 27% for metastatic diseases.

The study showed no difference between DCIS’s survival rates or early-stage estrogen receptor-positive invasive disease patients who underwent surgery within and after 120 days. It means that the delay in breast cancer treatment by the best cancer doctor in Delhi and outside does prove detrimental to the survival rate. 

New breast cancer guidelines

As the pandemic continues to affect lives globally, several new guidelines have been released that any Cancer Specialist in Delhi NCR and outside must adhere to. At the start of the year, cancer patients were considered to be vulnerable to the contagious COVID-19. However, studies until July 2020 have shown a lack of evidence corroborating such beliefs. Regardless, new breast cancer guidelines ask doctors not to delay any necessary anti-cancer treatment.

Moreover, patients are recommended to opt face-to-face consultations over telehealth visits but keeping the COVID-19 vulnerability in mind. Diagnosed patients that need hospitalization and soon-to-be outpatients should be tested for COVID-19 regardless of the symptoms. Ensuring the patients’ safety remains the hospital staff’s responsibility for a cancer specialist in Delhi NCR and the rest of the world.

Aside from this, new breast cancer guidelines have come out for cases of hereditary breast cancers. Women with a genetic mutation linked to breast cancer are eligible for treatment options like lumpectomy, nipple-sparing mastectomy, chemotherapy, and mastectomy, depending on the transformation area.

Best breast cancer treatment in Delhi

The fight against breast cancer is a long one, and the best cancer specialist can help encourage patients to continue fighting. Innovative technology and extensive knowledge of the disease are two other important factors that affect cancer treatment—as such, choosing an oncologist is a big decision because patients need a doctor who can fight with them. With education and training from AIIMS, Delhi, Dr. Manish Singhal, is one of best breast cancer specialist doctor in Delhi NCR . The oncologist known for his expertise in the field has several success stories that give patients hope. With Dr. Singhal, those affected by cancer are not patients but graceful warriors.

ALSO READ: Latest Breast Cancer updates from ASCO Annual Meeting 2020